RecruitingPhase 3NCT07404865
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Sponsor: Vor Biopharma
Allen, TX · Amarillo, TX · +44 more sites
Rheumatoid Arthritis clinical trials in Houston, TX
17 recruiting rheumatoid arthritis studies with a site in Houston, TX.
RecruitingPhase 2NCT07137598
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Sponsor: Hoffmann-La Roche
Colleyville, TX · Houston, TX · Tomball, TX · +15 more sites
RecruitingPhase 2NCT07620392
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Sponsor: Hoffmann-La Roche
Houston, TX · Tomball, TX · +3 more sites
RecruitingPhase 3NCT07621809
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Sponsor: Novartis Pharmaceuticals
Bellaire, TX · Corpus Christi, TX · Euless, TX · +17 more sites
RecruitingPhase 1 / Phase 2NCT07704580
Phase 1b/2 Study of IV Sarilumab in Adult With RA
Sponsor: Sanofi
El Paso, TX · Houston, TX · Mesquite, TX · +9 more sites
RecruitingPhase 2NCT07276581
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Sponsor: AstraZeneca
Austin, TX · Baytown, TX · Houston, TX · +26 more sites
RecruitingPhase 2NCT06972446
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Sponsor: AbbVie
Austin, TX · Carrollton, TX · Corpus Christi, TX · +46 more sites
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Dallas, TX · Fort Worth, TX · +48 more sites
RecruitingPhase 2NCT06570798
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Sponsor: Amgen
Houston, TX · +17 more sites
RecruitingPhase 3NCT04692493
RA-PRO PRAGMATIC TRIAL
Sponsor: University of Alabama at Birmingham
Colleyville, TX · Dallas, TX · El Paso, TX · +45 more sites
RecruitingPhase not listedNCT02418442
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Sponsor: Duke University
Dallas, TX · Houston, TX · +73 more sites
RecruitingPhase 1 / Phase 2NCT06733935
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Sponsor: Nkarta, Inc.
Dallas, TX · Houston, TX · +14 more sites
RecruitingPhase 2NCT07409103
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Sponsor: Elevara Medicines Limited
Baytown, TX · Houston, TX · Jackson, TX · +19 more sites
RecruitingPhase 1NCT05961592
R-2487 in Patients With Rheumatoid Arthritis
Sponsor: Rise Therapeutics LLC
Houston, TX · +5 more sites
RecruitingPhase not listedNCT04751396
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Sponsor: M.D. Anderson Cancer Center
Houston, TX
RecruitingPhase not listedNCT07123038
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
Sponsor: Sonoma Biotherapeutics, Inc.
Houston, TX · +9 more sites
RecruitingPhase not listedNCT03047369
The Myelin Disorders Biorepository Project
Sponsor: Children's Hospital of Philadelphia
Houston, TX · +21 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.